Related references
Note: Only part of the references are listed.Drug pH-Sensitive Release in Vitro and Targeting Ability of Polyamidoamine Dendrimer Complexes for Tumor Cells
Dan Liu et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2011)
Polyaspartamide-graft-Polymethacrylate Nanoparticles for Doxorubicin Delivery
Mariano Licciardi et al.
MACROMOLECULAR BIOSCIENCE (2011)
New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers
Konstantinos Gardikis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer
Yunching Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug
Ashay Jain et al.
JOURNAL OF CONTROLLED RELEASE (2010)
New Drug Delivery Nanosystem Combining Liposomal and Dendrimeric Technology (Liposomal Locked-In Dendrimers) for Cancer Therapy
Konstantinos Gardikis et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells
Ken-ichi Ogawara et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Flexible Filaments for in Vivo Imaging and Delivery: Persistent Circulation of Filomicelles Opens the Dosage Window for Sustained Tumor Shrinkage
David A. Christian et al.
MOLECULAR PHARMACEUTICS (2009)
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Tsutomu Ishihara et al.
PHARMACEUTICAL RESEARCH (2009)
Pegylated liposomal doxorubicin-associated hand-foot syndrome: Recommendations of an international panel of experts
Roger von Moos et al.
EUROPEAN JOURNAL OF CANCER (2008)
Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin
Awesh Kumar Yadav et al.
JOURNAL OF DRUG TARGETING (2008)
Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process
I. Hamada et al.
MOLECULAR IMMUNOLOGY (2008)
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome)
D. Lorusso et al.
ANNALS OF ONCOLOGY (2007)
Shape effects of filaments versus spherical particles in flow and drug delivery
Yan Geng et al.
NATURE NANOTECHNOLOGY (2007)
Squalenoyl nanomedicines as potential therapeutics
Patrick Couvreur et al.
NANO LETTERS (2006)
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
Si-Shen Feng
NANOMEDICINE (2006)
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Complement activation-related cardiac anaphylaxis in pigs:: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function
J Szebeni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex
AK Patri et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Designing dendrimers for biological applications
CC Lee et al.
NATURE BIOTECHNOLOGY (2005)
Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice
ZG Gao et al.
JOURNAL OF DRUG TARGETING (2005)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol
N Dos Santos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats
E Koh et al.
CIRCULATION JOURNAL (2004)
Nanoparticle and targeted systems for cancer therapy
L Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Ataxin-2 promotes apoptosis of human neuroblastoma cells
R Wiedemeyer et al.
ONCOGENE (2003)
Share Paper
